| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Nov 26, 2025 | OCULAR THERAPEUTIX, INC | Chief Scientific Officer | Sell | 46.3 | -3,469 | -1.39% | ✗ | $41.8K |
| Oct 2, 2025 | Oct 6, 2025 | OCULAR THERAPEUTIX, INC | Chief Scientific Officer | Sell | 42.5 | -10,502 | -4.04% | ✗ | $115.9K |
| Aug 25, 2025 | Aug 27, 2025 | OCULAR THERAPEUTIX, INC | Chief Scientific Officer | Sell | 46.3 | -3,063 | -1.16% | ✗ | $36.9K |
| May 23, 2025 | May 27, 2025 | OCULAR THERAPEUTIX, INC | Chief Scientific Officer | Sell | 46.3 | -3,024 | -1.14% | ✗ | $21.7K |
| Feb 24, 2025 | Feb 26, 2025 | OCULAR THERAPEUTIX, INC | Chief Scientific Officer | Sell | 46.3 | -3,061 | -1.14% | ✗ | $21K |
| Nov 25, 2024 | Nov 27, 2024 | OCULAR THERAPEUTIX, INC | Chief Scientific Officer | Sell | 46.3 | -2,948 | -1.08% | ✗ | $26.6K |
| May 12, 2022 | May 16, 2022 | OCULAR THERAPEUTIX, INC | Director | Buy | 91.3 | +15,000 | 62.50% | ✗ | $45.8K |
| Mar 15, 2019 | Mar 18, 2019 | OCULAR THERAPEUTIX, INC | Director | Buy | 95.0 | +24,000 | 100.00% | ✗ | $99.6K |